The Malvern, PA, multimodality vendor will use its RSNA exhibit to tout a range of new computer-aided detection (CAD) applications, from chest to mammography.
The company's syngo Lung CAD software received premarket approval (PMA) approval from the U.S. Food and Drug Administration (FDA) in October, just a month before the RSNA show. The software is a component of Siemens' syngo LungCare CT application and will be available on the company's syngo MultiModality Workplace workstation.
syngo Lung CAD is designed to help radiologists detect lung nodules on CT studies, and is the second generation of the company's nodule detection software, following the syngo LungCare NEV (nodule-enhanced viewing) application.
syngo Lung CAD was validated in a multicenter study in which 200 cases were reviewed by 17 radiologists. Use of the software as a second reader helped all participating radiologists increase their detection accuracy for clinically significant lung nodules, according to the company. The software is designed to find nodules 3 mm and larger.
syngo Colonography PEV (polyp enhanced viewing) is designed to detect polyps 6-20 mm and includes an automatic size measurement tool. Available as part of the syngo Colonography application, syngo Colonography PEV has received FDA 510(k) clearance and began shipping in February 2006.
In mammography, the company will show syngo MammoCAD, a work-in-progress application for analysis of full-field digital mammography (FFDM) studies. The software supports detection of masses and microcalcifications, and features a processing time of less than 90 seconds per four-image case. The software was released in Europe in June 2006 and is awaiting U.S. regulatory clearance.
Another new application, syngo TrueD, is designed for multimodality oncology studies, such as PET/CT and SPECT/CT, as well as CT or MR fused with PET and SPECT. It enables physicians to compare scans from two different time points, such as pre- and post-therapy, and includes image analysis and comparison tools. The software has received FDA clearance and has been available in the U.S. since February 2006.
Finally, syngo Auto EF is a CAD application for echocardiography studies that features automated detection and tracking of the borders of the left ventricle to provide automated measurements of the cardiac ejection fraction in adult patients, according to the company. The software is based on a new technique called learned pattern recognition (LPR), and is available on the company's Sequoia echocardiography system and syngo US Workplace workstation. U.S and international shipments began in April 2006.
By Brian Casey
AuntMinnie.com staff writer
November 3, 2006
Copyright © 2006 AuntMinnie.com
